UPDATE: Hologic Q1 Revenues Increase 34 Percent on Gen-Probe Acquisition
February 04, 2013
UPDATE: Hologic Q1 Revenues Increase 34 Percent on Gen-Probe Acquisition
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Hologic Women's Health Deal with Quest Viewed as Loss for Qiagen, Particularly on HPV Front
June 13, 2013 / PCR Insider - Gen-Probe Acquisition Drives up Hologic's Q2 Revenues 30 Percent
May 6, 2013 / GenomeWeb Daily News - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Dx Focus: BD Max Cdiff; Hologic Aptima HPV; Inostics BEAMing Tech; Veredus Labs VereFlu Test
April 11, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider